Logos Capital is a San Francisco-based venture capital firm backing healthcare and life sciences companies, with a portfolio concentrated in biotechnology, pharmaceuticals, oncology, HealthTech and medical devices. The firm invests across early and later-stage venture rounds, including Series A through later-stage financings, and has backed companies in the United States and Denmark. It is most relevant for life-science and healthcare founders raising institutional venture capital rather than seed-only funding.